Compounds > atropine
Page last updated: 2024-09-05

atropine and 8-hydroxy-2-(n-n-propyl-n-(3'-iodo-2'-propenyl)amino)tetralin

atropine has been researched along with 8-hydroxy-2-(n-n-propyl-n-(3'-iodo-2'-propenyl)amino)tetralin in 1 studies

Compound Research Comparison

Studies
(atropine)		Trials
(atropine)		Recent Studies (post-2010)
(atropine)		Studies
(8-hydroxy-2-(n-n-propyl-n-(3'-iodo-2'-propenyl)amino)tetralin)		Trials
(8-hydroxy-2-(n-n-propyl-n-(3'-iodo-2'-propenyl)amino)tetralin)		Recent Studies (post-2010) (8-hydroxy-2-(n-n-propyl-n-(3'-iodo-2'-propenyl)amino)tetralin)
26,7111,2591,697803

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kung, HF; Kung, MP; Zhuang, ZP1

Other Studies

1 other study(ies) available for atropine and 8-hydroxy-2-(n-n-propyl-n-(3'-iodo-2'-propenyl)amino)tetralin

ArticleYear
Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand.
    Journal of medicinal chemistry, 1993, Oct-15, Volume: 36, Issue:21

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; Iodine Radioisotopes; Ligands; Rats; Receptors, Serotonin; Stereoisomerism; Tetrahydronaphthalenes; Tritium

1993